These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 13530869)

  • 1. [Method of investigation of immunogenic properties of antirabies vaccines].
    PISKAREVA NA
    Vopr Virusol; 1957; 2(3):172-5. PubMed ID: 13530869
    [No Abstract]   [Full Text] [Related]  

  • 2. [Development of a method of inactivation of antirabies vaccine by ultraviolet rays. II. Immunogenic and antigenic properties of antirabies vaccine, inactivated by ultraviolet rays].
    PISKAREVA NA; IVANOV NP; PISAREVA NA
    Vopr Virusol; 1959; 4():615-9. PubMed ID: 14433265
    [No Abstract]   [Full Text] [Related]  

  • 3. [Development of a method for the inactivation of anti-rabies vaccine with ultraviolet rays. I. Effect of various conditions of action of ultraviolet rays on the infectious and immunogenic properties of fixed rabies virus].
    PISKAREVA NA; PISAREVA NA; IVANOV NP
    Vopr Virusol; 1959; 4():420-4. PubMed ID: 14433266
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study, by means of the conditioned reflex method, of the immunogenic power of formolized rabies and influenza vaccines].
    NICOLAU SS; MIRZA L; SAMUEL I
    Stud Cercet Inframicrobiol; 1961; 12(Suppl)():175-93. PubMed ID: 14479542
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental studies of the anti-rabies vaccine prepared under the influence of copper ions. Contribution concerning the mechanism of transformation of the pathogenic virus into an immunogenic one under the influence of the copper].
    NICOLAU SS; DRAGANESCU N; IONESCU NI; BOERU V; CIEN TIN HUAI
    Stud Cercet Inframicrobiol; 1961; 12():193-203. PubMed ID: 14479539
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunogenicity of antirabies vaccines].
    Albrycht H; Wysokińska T
    Med Dosw Mikrobiol; 1972; 24(2):141-51. PubMed ID: 5064355
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on dynamics of antibodies in dogs vaccinated with various types of antirabies vaccines].
    SHEN RM; ORLOVA NN; TUREVICH ST; NAZAROV VA; BEZELIUK MI
    Vopr Virusol; 1957; 2(3):156-61. PubMed ID: 13530865
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the problem of the allergenic properties of Fermi antirabies vaccine].
    ADO AD; KANCHURIN AKh
    Vopr Virusol; 1960; 5():14-9. PubMed ID: 13791923
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental investigations on the antirabies vaccine prepared under the action of copper ions. Contributions concerning the mechanism of transformation of the pathogenic virus into an immunogenic virus under the action of copper.
    NICOLAU SS; DRAGANESCU N; IONESCU NI; BOERU V; CIEN TIN HUAI
    Acta Biol Med Ger; 1962; 8():219-29. PubMed ID: 14479538
    [No Abstract]   [Full Text] [Related]  

  • 10. [Need for a restricted conference on rabies virus Flury and on antirabies vaccine].
    REMLINGER P
    Arch Inst Pasteur Alger; 1955 Sep; 33(3):233-6. PubMed ID: 13283616
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigenic value of lyophilized phenolized antirabies vaccine.
    VEERARAGHAVAN N; SUBRAHMANYAN TP
    Bull World Health Organ; 1961; 25(1):115-7. PubMed ID: 13925168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of the degree of antirabies immunity in mice with different capabilities for interferon formation].
    Karakuiumchian MK; Bektemirova MS; Polkovnikova VIa
    Vopr Virusol; 1973; 18(3):275-7. PubMed ID: 4769528
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on antirabies immunity in vaccinated cattle. I. Comparison of levels of neutralizing anti-rabies antibodies obtained in cattle using various vaccines, over a 1 year period].
    Atanasiu P; Fuenzalida E; Szyfres B; Acha P
    Ann Inst Pasteur (Paris); 1968 Mar; 114(3):339-48. PubMed ID: 5690808
    [No Abstract]   [Full Text] [Related]  

  • 14. [High-passage antirabies vaccine].
    BRICENO ROSSI AL; SEKERMESTROVICH N
    Rev Sanid Asist Soc; 1961 Sep; 26():633-6. PubMed ID: 13873013
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antirabies vaccine not producing post-vaccinal neuroparalytic complications].
    SVET-MOLDAVSKII Ia; SVET-MOLDAVSKII GIa
    Vopr Virusol; 1962; 7():68-71. PubMed ID: 14037810
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of antirabies vaccine as a coagulant].
    KOZHUKHAROV P; KHARIZANOVA T
    Suvr Med (Sofiia); 1955; 6(7):46-50. PubMed ID: 13299052
    [No Abstract]   [Full Text] [Related]  

  • 17. [The comparative course of human rabies in patients treated or not treated with antirabies vaccine and the therapeutic directives called for].
    NICOLAU SS; CONSTANTINESCU N; BIRZU N; ZAVATE O; MICU I; TEODOROVICI G
    Stud Cercet Inframicrobiol; 1961; 12(Suppl)():133-43. PubMed ID: 14479534
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary antirabies immunization of man with HEP flury virus vaccine.
    RUEGSEGGER JM; BLACK J; SHARPLESS GR
    Am J Public Health Nations Health; 1961 May; 51(5):706-16. PubMed ID: 13744541
    [No Abstract]   [Full Text] [Related]  

  • 19. [A study of the properties of antirabies gamma globulin in local application to wounds infected with the virus of street rabies].
    KOBRINSKII GD
    Vopr Virusol; 1960; 5():660-5. PubMed ID: 13757299
    [No Abstract]   [Full Text] [Related]  

  • 20. [Control of the immunizing power of antirabies vaccine by means of guinea pigs].
    CASTAGNOLI B; ORFEI Z
    Rend Ist Sup Sanit; 1955; 18(6):419-25. PubMed ID: 13310814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.